The platform analyses gene expression and cell states specific to individual cells, offering insights for disease diagnosis.

Large-scale study found testing led to 40% reduction in deaths from lung cancer and other causes over five years.

Edgardo S. Santos, MD, FACP, FASCO, highlighted how liquid biopsies are transforming lung cancer care by enabling faster, ...

Senseera, a liquid biopsy company pioneering chromatin epigenomics, announced the successful close of a $7.1 million seed ...

Groundbreaking research from the University of St Andrews School of Medicine has found that biomarker testing in individuals ...

Groundbreaking research from the University of St Andrews’ School of Medicine has found that biomarker testing in individuals at risk of lung cancer led to a major reduction in deaths.

Leading the forefront of neuro-oncology and neuroscience innovation, Hoag Family Cancer Institute and Hoag's Pickup Family ...

Background and objective Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic ...

Edgardo S. Santos, MD, FACP, FASCO, discussed the barriers to precision medicine in lung cancer treatment, including patient ...

Detailed price information for Biomark Diagnostics Inc (BUX-CN) from The Globe and Mail including charting and trades.

Breast cancer liquid biopsy industry is projected to witness a CAGR of 22.6% during the period 2024-2032. This growth can be ...

Biomarkers – measurable biological indicators found in blood, bodily fluids or tissues – reflect changes from normal biological processes to pathogenic ones that cause disease. They are also used to ...